Drugs / LID104
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05886088 | Feb 2024 → May 2026 overdue | type 2 diabetes mellitus | EMS | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LID104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05886088 ↗ |